Table 2.
Characteristics | n |
---|---|
Tumor size (cm) | |
≤2 | 505 |
2–4 | 815 |
≥4 | 216 |
No information | 9 |
Grade | |
1 | 128 |
2 | 607 |
3 | 770 |
No information | 40 |
Number of positive lymph nodes | |
0 | 779 |
1–3 | 508 |
≥4 | 254 |
No information | 4 |
Age (years) | |
20–29 | 12 |
30–39 | 96 |
40–49 | 281 |
50–59 | 393 |
60–69 | 438 |
70–79 | 267 |
≥80 | 58 |
PAM50 subtype | |
Normal | 159 |
Lum A | 532 |
Lum B | 380 |
HER2 | 190 |
Basal | 280 |
No information | 4 |
Treatment | |
None | 189 |
Chemotherapy | 40 |
Radiotherapy | 184 |
Hormone therapy | 309 |
Chemotherapy + radiotherapy | 163 |
Chemotherapy + hormone therapy | 28 |
Hormone therapy + radiotherapy | 481 |
Chemotherapy + hormone therapy + radiotherapy | 151 |
Abbreviations: HER2, receptor tyrosine-protein kinase erbB-2; Lum, luminal.